Loading organizations...

Instant lab tests on your smartphone
Neodocs has raised $2.1M across 2 funding rounds.
Key people at Neodocs.
Neodocs was founded in 2020 by Nikunj Malpani (Founder) and Anurag Meena (Founder) and Pratik Lodha (Founder).
Neodocs has raised $2.1M in total across 2 funding rounds.
Neodocs lets you perform instant lab tests on your smartphone. Our users are health optimizers and athletes who want to improve key nutritional markers for better performance.
You simply collect your sample, take a picture, and results are instantly generated.
We are the perfect team to build this. Anurag is a 3-time medical entrepreneur who’s built medical devices, Pratik has worked on AI/ML models for leading US banks, and Nikunj comes from a consulting background at Bain & Co.
We’re building your personal lab on your phone.
Key people at Neodocs.
Neodocs was founded in 2020 by Nikunj Malpani (Founder) and Anurag Meena (Founder) and Pratik Lodha (Founder).
Neodocs has raised $2.1M in total across 2 funding rounds.
Neodocs's investors include Aditya Misra, Ajay Yadav, Ramakant Sharma, Gaurav Agarwal, Harshad Reddy, Kunal Shah, Prashant Tandon, Rohit M.A., Varun Alagh, Viren Shetty, Vivek Gambhir, Gemba Capital.
Neodocs is a healthcare technology company that enables instant lab tests on a smartphone using AI-powered analysis of clinical test strips. Their product allows users to apply a sample (blood, urine, saliva) to a test card, scan it with a smartphone app, and receive accurate, clinically validated results within minutes, eliminating the need for traditional lab visits and long waiting times. The platform serves health-conscious individuals, athletes, and wellness seekers who want to monitor nutritional and performance biomarkers conveniently and proactively. Neodocs also supports B2B partnerships with pharmaceutical companies and is expanding internationally.
For an investment firm perspective, Neodocs embodies a mission to democratize healthcare diagnostics by making lab-quality testing accessible, affordable, and instant via smartphones. Their investment philosophy likely centers on leveraging AI and mobile technology to disrupt traditional healthcare delivery, focusing on sectors such as digital health, medical devices, and consumer health services. Their impact on the startup ecosystem includes fostering innovation in point-of-care diagnostics and enabling scalable health monitoring solutions in emerging and developed markets[1][2][3].
Neodocs was co-founded by Anurag Meena, Pratik Lodha, and Nikunj Malpani. Anurag brings experience in medical devices and healthcare startups, Pratik specializes in AI/ML product development, and Nikunj has a background in consulting and business strategy. The idea emerged from the need to overcome the delays and logistical challenges of traditional lab testing, especially in rural and remote areas. Early traction included participation in accelerator programs like Y Combinator (Summer 2021 batch) and collaborations with institutions such as Taiwan Medical University and tech partners like Google and Nvidia. The company quickly secured seed funding and established partnerships with major pharma companies like Cipla and Bayer[1][2][3][5].
Neodocs rides the growing trend of digital health democratization and point-of-care diagnostics, accelerated by advances in AI, smartphone penetration, and consumer demand for proactive health management. The timing is critical as healthcare systems worldwide seek scalable, low-cost diagnostic solutions, especially in underserved regions. Market forces such as rising chronic disease prevalence, increasing health awareness, and the shift towards telemedicine favor Neodocs’ model. By enabling instant, accurate testing on ubiquitous devices, Neodocs influences the broader ecosystem by reducing dependency on centralized labs, empowering users with data, and fostering integration between diagnostics and digital health platforms[1][2][4][7].
Neodocs is poised for significant growth as it expands its test portfolio to cover lipid profiles, liver function, fertility, and more, aiming for 100 million smartphone tests in the next three years. Trends shaping their journey include AI advancements, personalized medicine, and global demand for accessible diagnostics. Their influence may evolve from a consumer-focused health tool to a critical component in healthcare delivery and chronic disease management worldwide. Continued partnerships with pharma, tech accelerators, and international expansion will likely enhance their ecosystem impact and market penetration, making instant smartphone lab testing a mainstream health practice[1][7].
Neodocs exemplifies how combining AI, mobile technology, and clinical science can revolutionize diagnostics, making health monitoring as effortless and immediate as checking a message on your phone.
Neodocs has raised $2.1M across 2 funding rounds. Most recently, it raised $2.0M Seed in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $2.0M Seed | Aditya Misra | Ajay Yadav, Ramakant Sharma, Gaurav Agarwal, Harshad Reddy, Kunal Shah, Prashant Tandon, Rohit M.A., Varun Alagh, Viren Shetty, Vivek Gambhir, Gemba Capital, Titan Capital, Y Combinator |
| Aug 1, 2021 | $130K Seed | Venture Catalysts | India's First Integrated Incubator |